minocycline
minocycline: sourced relationships with 2 companies · 4 clinical trials tracked · 3 FDA decisions.
minocycline evidence translation
What we can confirm
3 FDA records · 4 tracked trials
What it means
What to watch
Prepared research question
What is verified about minocycline, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence4 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (2)
| Company | Dated record stage |
|---|---|
| Bausch Health Companies Inc. (BHC) Reported 2006-05-08 · Current development: unknownSource | Approved |
| Journey Medical Corp (DERM) Inflammatory lesions of rosacea in adults | Approved |
Clinical Trial Registry Records (4)
Effect of Oral Minocycline in Patients With Acute Stroke - a Randomized, Open Label, Prospective Trial
Primary endpoint: Change in National Institutes of Health Stroke Scale (NIHSS) Score at Day 7 post stroke
Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury
Primary endpoint: Change in Glasgow Outcome Scale-Extended (GOSE 2-Way)
A Phase 2, Open-Label, Randomized Trial Evaluating the Impact of Enhanced Versus Standard Dermatologic Management on Selected Dermatologic Adverse Events Among Patients With Locally Advanced or Metastatic EGFR-Mutated NSCLC Treated First-Line With Amivantamab + Lazertinib
Primary endpoint: Number of Participants With Grade Greater Than or Equal to (>=) 2 Dermatologic Adverse Events of Interest (DAEIs) Within 12 Weeks After Initiation of Anticancer Treatment
STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)
Primary endpoint: Proportion of STAR-TER subjects with a negative MRSA culture at Day 28 vs. observational arm of historic STAR-Too trial
FDA Decisions3 records
Frequently asked questions
Which companies have sourced relationships with minocycline?
minocycline has dated SEC/FDA relationship records for Bausch Health Companies Inc., Journey Medical Corp.
How many clinical trials involve minocycline?
BioSniper tracks 4 clinical trials involving minocycline.
What is minocycline's latest FDA decision?
The most recent tracked FDA decision for minocycline is Approval for 1 INDICATIONS AND USAGE ZILXI is indicated for the treatment of inflammatory lesions of rosacea in adults [see Clinical Studies ( 14 )] . Limitations of Use This formulation of minocycline has not been evaluated in the treatment of infections. To reduce the development of drug-resistant bacteria as well as to maintain the effectiveness of other antibacterial drugs, ZILXI should be used only as indicated [see Warnings and Precautions ( 5.14 )] . ZILXI is a tetracycline-class drug indicated for the treatment of inflammatory lesions of rosacea in adults. ( 1 ) Limitations of Use This formulation of minocycline has not been evaluated in the treatment of infections. To reduce the development of drug-resistant bacteria as well as to maintain the effectiveness of other antibacterial drugs, ZILXI should be used only as indicated ( 1 )., dated May 28, 2020.